Entheon Biomedical Corp. announced that Dr. David Erritzoe, the current Clinical Director of the Imperial College's Center for Psychedelic Research, has been appointed to Entheon's Advisory Board. Dr. Erritzoe has significant experience in psychiatry, neuropsychopharmacology and psychedelic research. He is currently leading a new National Health Service (BHS) based research clinic, the CIPPRes Clinic, a collaborative, multidisciplinary research initiative between the Imperial College in London and the St. Charles Hospital.